Efficacy and safety of selexipag in patients with pulmonary arterial hypertension in real-life: early results of RAMPHA study

21 May 2022 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Focus on the right side Pulmonary Hypertension HFA Premium Access Heart Failure 2022

ESC 365 is supported by

ESC 365 is supported by